Drug factory · FDA FEI 3013002864
Xiamen LP Pharmaceutical Co., Ltd.
2010 Wengjiao West Road, Xiamen, China
Problems found, fixed voluntarily at FDA's last inspection, Apr 19, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2018: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Aripiprazole | Makes it | Carwin Pharmaceutical Associates, LLC | 15370-401, 15370-402, 15370-403 |
| Clonidine | Makes it, tests it, packages it and labels it | Solco Healthcare U.S., LLC, Xiamen LP Pharmaceutical Co., Ltd. | 43547-435, 71034-001 |
| Topiramate | Makes it, tests it, packages it and labels it | Vitruvias Therapeutics, Inc. | 69680-177, 69680-178, 69680-179 +2 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Apr 19, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Nov 16, 2018 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack.